SILVERSUN TECHNOLOGIES INC (SSNT)

US82846H2076 - Common Stock

14.35  -0.51 (-3.43%)

After market: 14.35 0 (0%)

Fundamental Rating

3

Overall SSNT gets a fundamental rating of 3 out of 10. We evaluated SSNT against 277 industry peers in the Software industry. SSNT has only an average score on both its financial health and profitability. SSNT is valued expensive and it does not seem to be growing.



4

1. Profitability

1.1 Basic Checks

SSNT had negative earnings in the past year.
SSNT had a positive operating cash flow in the past year.
In multiple years SSNT reported negative net income over the last 5 years.
Of the past 5 years SSNT 4 years had a positive operating cash flow.

1.2 Ratios

SSNT has a Return On Assets of -5.22%. This is comparable to the rest of the industry: SSNT outperforms 56.52% of its industry peers.
SSNT has a Return On Equity (-14.33%) which is comparable to the rest of the industry.
SSNT has a Return On Invested Capital of 14.80%. This is amongst the best in the industry. SSNT outperforms 93.12% of its industry peers.
Industry RankSector Rank
ROA -5.22%
ROE -14.33%
ROIC 14.8%
ROA(3y)-2.42%
ROA(5y)5.94%
ROE(3y)-6.21%
ROE(5y)12.04%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 3.08%, SSNT is in the better half of the industry, outperforming 71.38% of the companies in the same industry.
SSNT's Operating Margin has improved in the last couple of years.
The Gross Margin of SSNT (39.66%) is worse than 73.91% of its industry peers.
SSNT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.08%
PM (TTM) N/A
GM 39.66%
OM growth 3Y79.19%
OM growth 5Y25.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5Y-0.8%

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SSNT is creating some value.
Compared to 1 year ago, SSNT has more shares outstanding
SSNT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SSNT has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 6.33 indicates that SSNT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.33, SSNT is in the better half of the industry, outperforming 76.45% of the companies in the same industry.
The Debt to FCF ratio of SSNT is 4.53, which is a neutral value as it means it would take SSNT, 4.53 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SSNT (4.53) is better than 61.59% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that SSNT is not too dependend on debt financing.
The Debt to Equity ratio of SSNT (0.17) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 4.53
Altman-Z 6.33
ROIC/WACC1.49
WACC9.93%

2.3 Liquidity

A Current Ratio of 1.02 indicates that SSNT should not have too much problems paying its short term obligations.
With a Current ratio value of 1.02, SSNT is not doing good in the industry: 76.81% of the companies in the same industry are doing better.
SSNT has a Quick Ratio of 1.02. This is a normal value and indicates that SSNT is financially healthy and should not expect problems in meeting its short term obligations.
SSNT's Quick ratio of 1.02 is on the low side compared to the rest of the industry. SSNT is outperformed by 75.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02

2

3. Growth

3.1 Past

The earnings per share for SSNT have decreased strongly by -234.08% in the last year.
Looking at the last year, SSNT shows a very strong growth in Revenue. The Revenue has grown by 21.18%.
The Revenue has been growing slightly by 5.86% on average over the past years.
EPS 1Y (TTM)-234.08%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2QN/A
Revenue 1Y (TTM)21.18%
Revenue growth 3Y9.77%
Revenue growth 5Y5.86%
Revenue growth Q2Q18.52%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

SSNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SSNT indicates a somewhat cheap valuation: SSNT is cheaper than 78.99% of the companies listed in the same industry.
SSNT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 164.93
EV/EBITDA 26.96

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

SSNT has a Yearly Dividend Yield of 1.39%. Purely for dividend investing, there may be better candidates out there.
SSNT's Dividend Yield is rather good when compared to the industry average which is at 12.74. SSNT pays more dividend than 93.48% of the companies in the same industry.
With a Dividend Yield of 1.39, SSNT pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.39%

5.2 History

SSNT has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of SSNT are negative and hence is the payout ratio. SSNT will probably not be able to sustain this dividend level.
DP-98.18%
EPS Next 2YN/A
EPS Next 3YN/A

SILVERSUN TECHNOLOGIES INC

NASDAQ:SSNT (5/10/2024, 7:20:51 PM)

After market: 14.35 0 (0%)

14.35

-0.51 (-3.43%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap76.34M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.39%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.22%
ROE -14.33%
ROCE
ROIC
ROICexc
ROICexgc
OM 3.08%
PM (TTM) N/A
GM 39.66%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.66
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-234.08%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)21.18%
Revenue growth 3Y9.77%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y